For all information and guidance relating to Opioid Prescribing on the SY MO website click here
Opioid Dependence
Rationale:1,2
*Controlled Drug*
*Specialist Clinic Prescribing only*
NICE TA114 Methadone and buprenorphine for the management of opioid dependence
Managing Opioid dependance Alcohol disorders - maintenance of abstinence
Red for new patients. Amber-G for pre-exisiting patients
Rationale 1,2
Naltrexone may be continued to be prescribed in Primary Care for pre-existing/historical patients, however no new patients should be initiated by, or transferred into, Primary Care. -
Naltrexone can be offered in combination with an individual
psychological intervention (cognitive behavioural therapies, behavioural therapies or social network and environment-based therapies) focused specifically on alcohol misuse
NICE CG115 Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence
Naltrexone is recommended as a treatment option in detoxified formerly opioid-dependent people who are highly motivated to remain in an abstinence programme
Naltrexone should only be administered under adequate supervision to people who have been fully informed of the potential adverse effects of treatment. It should be given as part of a programme of supportive care.
The effectiveness of naltrexone in preventing opioid misuse in people being treated should be reviewed regularly. Discontinuation of naltrexone treatment should be considered if there is evidence of such misuse.
Opioid dependence
Rationale 1,2
*Specialist Clinic Prescribing only*